MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$3,775,804
EPS
-$0.95
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Collaboration revenue
0
-
1,000,000
4,656.5*
Research and development
2,425,551
1,884,907
1,886,076
556,153*
General and administrative
1,380,905
2,344,513
1,963,346
-2,533,980*
Total operating expenses
3,806,456
4,229,420
3,849,422
-1,977,827*
Loss from operations
-3,806,456
-4,229,420
-2,849,422
1,982,483.5*
Other income
0
720,102
-
1,081,986.5*
Foreign exchange gain (loss)
30,652
18,196
-152,884
14,963*
Loss before provision for income taxes
-3,775,804
-3,491,122
-3,002,306
-
Provision for income taxes
0
-
158,400
-
Net gain
-3,775,804
-3,491,122
-3,160,706
3,079,433
Basic EPS
-0.95
-0.89
-1.56
-0.826
Diluted EPS
-0.95
-0.89
-1.56
-0.826
Basic Average Shares
3,965,220
3,921,641
2,022,818
-3,727,028
Diluted Average Shares
3,965,220
3,921,641
2,022,818
-3,727,028
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
SONN Income Statement Sankey Diagram
Sankey diagram visualizing SONN income statement for the period
Net gain
-$3,775,804
(-7.71%↓ Y/Y)
Loss before
provision for income taxes
-$3,775,804
Foreign exchange gain
(loss)
$30,652
(32.64%↑ Y/Y)
Loss from operations
-$3,806,456
(-7.87%↓ Y/Y)
Total operating
expenses
$3,806,456
(7.87%↑ Y/Y)
Research and development
$2,425,551
(40.45%↑ Y/Y)
General and
administrative
$1,380,905
(-23.35%↓ Y/Y)
Buy us a coffee
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Sonnet BioTherapeutics Holdings, Inc. (SONN)